Zydus Cadila, an Indian injectables maker, said it reached a deal with Russia’s Pharm Aid to manufacture its varicella vaccine for the Russian Federation.

Japanese CDMO Ajinomoto Althea is expanding production at its recently completed high-potency products manufacturing facility in San Diego.

Catalent has agreed to pay $950 million to buy Cook Pharmica and its extensive biologics manufacturing operation in Bloomington, Indiana.

Japan's Fujifilm Diosynth Biotechnologies has completed a $9 million expansion project of its cell manufacturing facilities in the U.K.

New Jersey-based CDMO Catalent signed a deal with US WorldMeds to manufacture lofexidine, an investigational drug used to treat opioid withdrawal.

Thermo Fisher Scientific has completed its $7.2 billion acquisition of CDMO Patheon, weeks after Lonza completed its $5.5 billion buyout of Capsugel.

The worst is over for a CordenPharma sterile manufacturing plant in Italy that was slapped last year with an FDA warning letter.

Swiss CDMO Micro-Sphere plans to invest $22 million to expand its facility for spray drying and capsule filling along the Swiss-Italian border.

Soligenix just got another $2.5 million awarded from an NIAID contract to support manufacturing of a heat-stable ricin vaccine for future studies.